Executive Team


Arvindkumar  Dholariya

Arvindkumar Dholariya is the Chief Executive Officer and Managing Director of Platonic Pharmaceuticals. An inspiring and visionary leader having over 28 years of experience in pharmaceutical industry in Sales & Marketing, International Business, Supply Chain Management & Operations. Arvind served as Chief Executive – Global Formulations with RPG Lifesciences and Senior Director – Sales & Marketing with Dr. Reddy’s Laboratories.

He has well-rounded experience of integrated business value chain, capabilites in unlocking emerging market advantages with experience of running business arms in APAC, Central & Latin American countries & Africa. During his professional career he has manged large number of in licensing assignments and brought new products to India and has been instrumental in collaborationg with institutions of repute in the country and USA.

He has always been a leader at the forefront in the establishing transformational, profitable, sustained business results, enhancing market share and build capabilities.

An avid reader having interest in classical music, Arvind  is a science graduate by qualification has been through the training on SFE & SFA by IBC, Singapore and Sales & Marketing Management at ASCI, Hydrabad.

He has been distinguished speaker with various management colleges and national & international forums.

Prakash G. Patel

Prakash Patel is Group Therapy Manager & Division Head at Platonic Pharmaceuticals. Prakash is a result driven professional who is credited with creating with mega brands & successful business verticals. A visionary strategist, he has a strong interest in strategic planning, defining long-range goals & is capable of pursuing the same through tactical planning & effective execution. Prakash has a passion for developing people. He is skilful in driving cross-funtional terms to achieve organizational objectives.

Prakash is a science graduate by qualificaion has been through the training on sales & marketing management at asci, Hydrabad.


Comments are closed.